Drugs / Flublock
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04077424 Comparator | Oct 2019 → Feb 2020 | — | Vanderbilt University Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flublock | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04077424 ↗ |
| Known as | Flublok | “Recombinant Hemagglutinin vaccine (Flublok)” NCT04077424 ↗ |